Inventor · disambiguated record
Uma Sinha
Also filed as: SINHA UMA
32 granted patents·40 pending applications·492 citations·filing 1993–2024
98Inventor score
Files withPORTOLA PHARM INC24COR THERAPEUTICS INC11ALEXION PHARMA INC10SINHA UMA9EIDOS THERAPEUTICS INC3
Top patents by PatentIndex Score
72 records- 0197US8153590B2Antidotes for factor Xa inhibitors and methods of using the sameLU GENMIN·Filed 2008·Granted Apr 10, 2012·56 cites·18 claims
- 0296US8268783B2Antidotes for factor Xa inhibitors and methods of using the sameSINHA UMA·Filed 2010·Granted Sep 18, 2012·40 cites·25 claims
- 0395US9388401B2Antidotes for factor Xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2014·Granted Jul 12, 2016·18 cites·19 claims
- 0495US9062298B2Antidotes for factor XA inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2013·Granted Jun 23, 2015·21 cites·18 claims
- 0595US8889129B2Antidotes for factor Xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2013·Granted Nov 18, 2014·18 cites·22 claims
- 0695US8455441B2Antidotes for factor Xa inhibitors and methods of using the sameLU GENMIN·Filed 2012·Granted Jun 4, 2013·27 cites·18 claims
- 0794US10954503B2Antidotes for factor Xa inhibitors and methods of using the sameALEXION PHARMA INC·Filed 2019·Granted Mar 23, 2021·4 cites·12 claims
- 0894US9109046B2Antidotes for factor Xa inhibitors and methods of using the sameSINHA UMA·Filed 2012·Granted Aug 18, 2015·21 cites·17 claims
- 0994US8455439B2Antidotes for factor Xa inhibitors and methods of using the same in combination with blood coagulating agentsLU GENMIN·Filed 2009·Granted Jun 4, 2013·32 cites·13 claims
- 1093US9587233B2Antidotes for factor XA inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2015·Granted Mar 7, 2017·10 cites·7 claims
- 1192US9056106B2Unit dose formulation of antidotes for factor Xa inhibitors and methods of using the sameSINHA UMA·Filed 2010·Granted Jun 16, 2015·20 cites·8 claims
- 1291US10675335B2Antidotes for factor Xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2016·Granted Jun 9, 2020·3 cites·3 claims
- 1390US10765726B2Unit dose formulation of antidotes for factor Xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2017·Granted Sep 8, 2020·3 cites·20 claims
- 1490US10004725B2Methods of treatmentGLOBAL BLOOD THERAPEUTICS INC·Filed 2016·Granted Jun 26, 2018·18 cites·6 claims
- 1588US11058668B2Methods of treating TTR amyloidosis using AG10EIDOS THERAPEUTICS INC·Filed 2019·Granted Jul 13, 2021·6 cites·14 claims
- 1688US2024082367A1Antidotes for factor xa inhibitors and methods of using the sameALEXION PHARMA INC·Filed 2023·Application pending·0 cites
- 1788US2025186563A1Unit dose formulation of antidotes for factor xa inhibitors and methods of using the sameALEXION PHARMA INC·Filed 2024·Application pending·0 cites
- 1887US12070449B2Methods of treating TTR amyloidosis using AG10EIDOS THERAPEUTICS INC·Filed 2021·Granted Aug 27, 2024·1 cites·20 claims
- 1986US11839646B2Antidotes for factor Xa inhibitors and methods of using the sameALEXION PHARMA INC·Filed 2020·Granted Dec 12, 2023·1 cites·12 claims
- 2086US10190111B2Antidotes for factor Xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2017·Granted Jan 29, 2019·3 cites·10 claims
- 2186US2023383276A1Process for making recombinant antidote to factor xa inhibitorALEXION PHARMA INC·Filed 2023·Application pending·0 cites
- 2285US8404724B2Unit dose formulations and methods of treating thrombosis with an oral factor Xa inhibitorSINHA UMA·Filed 2007·Granted Mar 26, 2013·9 cites·5 claims
- 2385US2024189401A1Unit dose formulation of antidotes for factor xa inhibitors and methods of using the sameALEXION PHARMA INC·Filed 2023·Application pending·0 cites
- 2483US5721214AInhibitors of factor XaCOR THERAPEUTICS INC·Filed 1995·Granted Feb 24, 1998·49 cites·7 claims
- 2582US5583107AAgents affecting thrombosis and hemostasisCOR THERAPEUTICS INC·Filed 1994·Granted Dec 10, 1996·44 cites·14 claims
- 2681US2025041276A1Methods of treating ttr amyloidosis using ag10EIDOS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2779US5837679AAgents affecting thrombosis and hemostasisCOR THERAPEUTICS INC·Filed 1995·Granted Nov 17, 1998·25 cites·46 claims
- 2878US12357576B2Formulations of triphenyl calcilytic compoundsCALCILYTIX THERAPEUTICS INC·Filed 2023·Granted Jul 15, 2025·1 cites·11 claims
- 2978US8455440B2Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitorSINHA UMA·Filed 2011·Granted Jun 4, 2013·3 cites·24 claims
- 3078US5990079AAgents affecting thrombosis and hemostasisCOR THERAPEUTICS INC·Filed 1998·Granted Nov 23, 1999·22 cites·16 claims
- 3178US2022098565A1Process for making recombinant antidote to factor xa inhibitorALEXION PHARMA INC·Filed 2021·Application pending·0 cites
- 3277US2023000957A1Unit dose formulation of antidotes for factor xa inhibitors and methods of using the sameALEXION PHARMA INC·Filed 2022·Application pending·0 cites
- 3375US2021340515A1Antidotes for factor xa inhibitors and methods of using the sameALEXION PHARMA INC·Filed 2021·Application pending·0 cites
- 3471US2019127720A1Process for making recombinant antidote to factor xa inhibitorPORTOLA PHARM INC·Filed 2018·Application pending·0 cites
- 3571US2021085762A1Unit dose formulation of antidotes for factor xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2020·Application pending·0 cites
- 3669US8946219B2Combination therapy with a compound acting as a platelet ADP receptor inhibitorCONLEY PAMELA B·Filed 2010·Granted Feb 3, 2015·2 cites·13 claims
- 3769US6245743B1Inhibitors of factor XaCOR THERAPEUTICS INC·Filed 1996·Granted Jun 12, 2001·20 cites·11 claims
- 3867US2021379163A1Inhibition of tissue factor pathway inhibitor with factor xa derivativesALEXION PHARMA INC·Filed 2021·Application pending·0 cites
- 3966US2017240879A1Process for making recombinant antidote to factor xa inhibitorPORTOLA PHARM INC·Filed 2016·Application pending·0 cites
- 4066US2020129597A1MODULATION OF FACTOR Xa INHIBITOR-MEDIATED BLOOD LOSS BY PARTIAL AND TRANSIENT ADMINISTRATION OF ANTIDOTEPORTOLA PHARM INC·Filed 2019·Application pending·0 cites
- 4165US2013230901A1Process for making recombinant antidote to factor xa inhibitorPORTOLA PHARM INC·Filed 2013·Application pending·0 cites
- 4265US2017014492A1Unit dose formulation of antidotes for factor xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2016·Application pending·0 cites
- 4363US2015352194A1Inhibition of tissue factor pathway inhibitor with factor xa derivativesPORTOLA PHARM INC·Filed 2013·Application pending·0 cites
- 4463US2015376592A1Process for making recombinant antidote to factor xa inhibitorPORTOLA PHARM INC·Filed 2015·Application pending·0 cites
- 4563US2015025011A1Unit dose formulation of antidotes for factor xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2014·Application pending·0 cites
- 4663US2018333469A1Inhibition of tissue factor pathway inhibitor with factor xa derivativesPORTOLA PHARM INC·Filed 2018·Application pending·0 cites
- 4761US2016038474A1Compositions and methods for the modulation of hemoglobin (s)GLOBAL BLOOD THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 4861US2016015793A1Modulation of factor xa inhibitor mediated blood loss by partial and transient administration of antidotePORTOLA PHARMACUETICALS INC·Filed 2013·Application pending·0 cites
- 4961US2018185459A1MODULATION OF FACTOR Xa INHIBITOR-MEDIATED BLOOD LOSS BY PARTIAL AND TRANSIENT ADMINISTRATION OF ANTIDOTEPORTOLA PHARM INC·Filed 2018·Application pending·0 cites
- 5060US2014271591A1Compositions and methods for the modulation of hemoglobin (s)GLOBAL BLOOD THERAPEUTICS INC·Filed 2013·Application pending·0 cites
Showing the top 50 of 72 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Uma Sinha files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →